Omeros Corporation Description
Omeros Corporation, a clinical-stage biopharmaceutical company, engages in discovering, developing, and commercializing products targeting inflammation, coagulopathies, and disorders of the central nervous system. The company derives product candidates from its proprietary PharmacoSurgery platform that is designed to enhance clinical outcomes of patients undergoing ophthalmological, arthroscopic, urological, and other surgical and medical procedures. The company's product candidates include OMS302, which has completed two Phase III clinical trials for use during intraocular lens replacement surgery, including cataract and other lens replacement surgery; OMS103HP that is in Phase III program for use during arthroscopic procedures comprising partial meniscectomy surgery; and OMS201, which has completed Phase I/Phase II studies for use during urological procedures, including ureterscopy for removal of ureteral or renal stones. Its clinical programs also consist of OMS824, which is in Phase I clinical trial for the treatment of cognitive disorders, including schizophrenia; and OMS405 that is in Phase II clinical trial for the treatment and prevention of addiction to substances of abuse. The company's preclinical product development programs comprise OMS721 for hemolytic uremic syndrome, paroxysmal nocturnal hemoglobinuria, wet age-related macular degeneration, ischemia-reperfusion injury, and transplant-related complications; OMS527 for addictions and compulsive disorders, and movement disorders; and OMS616 for surgical and traumatic bleeding. In addition, it is developing G protein-coupled receptors (GPCR) programs for multiple disorders. Omeros Corporation was incorporated in 1994 and is based in Seattle, Washington.
Classification
Sector:
Healthcare
Industry:
Biotechnology
Keywords:
Medicine
Biopharmaceutical
Surgery
Inflammation
Disorders
Clinical Research
Ophthalmology
Clinical Trial
Urology
Schizophrenia
Macular Degeneration
Cataracts
Perfusion
Wet Age Related Macular Degeneration
Hemoglobin
Surgical Specialties
Movement Disorders
Cognitive Disorders
Ischemia
Addiction
Intraocular Lens
Arthroscopy
Hemoglobinuria
Paroxysmal Nocturnal Hemoglobinuria
Hemolytic Uremic Syndrome